ConductScience.org, home

Paper40052411

ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.

Lai X and 7 others. Cancer Sci, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma. Papers, record 40052411. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40052411

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.
PubMed
Journal
Cancer Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-06-04
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lai XXiaoyi
2Yoda HHiroyukihttps://orcid.org/0000-0002-5528-8940
3Qiao YYuming
4Kida YYuki
5Takenaga KKeizohttps://orcid.org/0000-0002-5341-6742
6Shinozaki YYoshinao
7Koshikawa NNobuko
8Takatori AAtsushihttps://orcid.org/0000-0002-2184-6721

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeuroblastomaMajor topic
N-Myc Proto-Oncogene ProteinMajor topic
Ataxia Telangiectasia Mutated ProteinsMajor topic
DNA RepairMajor topic
NylonsMajor topic
Humans
Animals
Cell Line, Tumor
Mice
Xenograft Model Antitumor Assays
Apoptosis
Drug Synergism
DNA Damage
Gene Amplification
Pyrroles
Imidazoles
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JP22zf0127001Japan Agency for Medical Research and Development (AMED)-MoonshotPubMed
JP23zf0127001Japan Agency for Medical Research and Development (AMED)-MoonshotPubMed
JP22H04923JSPS KAKENHIPubMed
JP22K07245JSPS KAKENHIPubMed
Takeda Science FoundationPubMed
JP22ek0210168AMEDPubMed
JPMJSP2109JST SPRINGPubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132354033ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms.Cancers (Basel)2020https://conductscience.org/library/papers/32354033PubMed
228625637A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer.Lung Cancer2017https://conductscience.org/library/papers/28625637PubMed
321173028MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.Mol Cancer Res2011https://conductscience.org/library/papers/21173028PubMed
431545289RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.Biomed Pharmacother2019https://conductscience.org/library/papers/31545289PubMed
535078817ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib.Cancer Res2022https://conductscience.org/library/papers/35078817PubMed
617028100Expression of C-terminal deleted p53 isoforms in neuroblastoma.Nucleic Acids Res2006https://conductscience.org/library/papers/17028100PubMed
728530640Genetic regulation of the RUNX transcription factor family has antitumor effects.J Clin Invest2017https://conductscience.org/library/papers/28530640PubMed
833585251MYCN Function in Neuroblastoma Development.Front Oncol2020https://conductscience.org/library/papers/33585251PubMed
925605849Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.J Clin Oncol2015https://conductscience.org/library/papers/25605849PubMed
1037020276ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.BMC Cancer2023https://conductscience.org/library/papers/37020276PubMed
1126117536The NEIL glycosylases remove oxidized guanine lesions from telomeric and promoter quadruplex DNA structures.Nucleic Acids Res2015https://conductscience.org/library/papers/26117536PubMed
1231707688
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer.
Invest New Drugs2020https://conductscience.org/library/papers/31707688PubMed
1325274755Therapeutic strategies to inhibit MYC.Cold Spring Harb Perspect Med2014https://conductscience.org/library/papers/25274755PubMed
1432577161MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma.Oncotarget2020https://conductscience.org/library/papers/32577161PubMed
1536634205Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma.Oncotarget2023https://conductscience.org/library/papers/36634205PubMed
1620100802The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus.Nucleic Acids Res2010https://conductscience.org/library/papers/20100802PubMed
1735857500RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.Sci Adv2022https://conductscience.org/library/papers/35857500PubMed
1839395371Poly (ADP-ribose) polymerase inhibitor sensitized DNA damage caused by an alkylating pyrrole-imidazole polyamide targeting MYCN in neuroblastoma cells.Biochem Biophys Res Commun2024https://conductscience.org/library/papers/39395371PubMed
1927974823Roles of human POLD1 and POLD3 in genome stability.Sci Rep2016https://conductscience.org/library/papers/27974823PubMed
2028394338PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.Oncogene2017https://conductscience.org/library/papers/28394338PubMed

See all 42 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42517066MYC in Oncogenesis and Therapeutic Implications.MedComm (2020)2026https://conductscience.org/library/papers/42517066PubMed
41994561Targeted therapies in pediatric oncology: A start.Mol Ther Oncol2026https://conductscience.org/library/papers/41994561PubMed
41733731Identification of potential clinical markers associated with prognosis of neuroblastoma.Discov Oncol2026https://conductscience.org/library/papers/41733731PubMed
41193393Targeting Wnt/β-Catenin Pathway by DNA Alkylating Pyrrole-Imidazole Polyamide in Colon Cancer.Cancer Sci2026https://conductscience.org/library/papers/41193393PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
MYCN4613PubTator's text mininghttps://conductscience.org/library/genes/4613NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40052411

GET https://conductscience.org/api/papers/v1/40052411/references?page=2